Related Experiment Video
Updated: Feb 8, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Impaired ankle-brachial index in antiphospholipid syndrome: Beyond the traditional risk factors
Simona Caraiola1,2, Ciprian Jurcut3, Alina Dima1,2
1Department of Internal Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Insights
Antiphospholipid syndrome (APS) patients have higher atherosclerosis risk. Anti-beta 2-glycoprotein I (aβ2GPI) IgG antibodies predict abnormal ankle-brachial index (ABI), a marker of atherosclerosis, in these patients.
Area of Science:
- Rheumatology
- Cardiology
- Immunology
Background:
- Antiphospholipid syndrome (APS) is linked to an elevated risk of atherosclerosis.
- Atherosclerosis, a hardening of the arteries, poses significant cardiovascular risks.
Purpose of the Study:
- To identify predictors of an abnormal ankle-brachial index (ABI) in APS patients.
- The ABI serves as a surrogate marker for atherosclerosis, assessing peripheral artery disease.
Main Methods:
- Ankle-brachial index (ABI) was measured in 106 APS patients.
- Cardiovascular risk factors were evaluated, and APS-associated antibodies were determined in 73 patients.
Main Results:
- 28.3% of APS patients exhibited a low ABI, indicating atherosclerosis.
- Higher titers of anti-beta 2-glycoprotein I (aβ2GPI) IgG antibodies were associated with abnormal ABI.
- Multivariate analysis confirmed aβ2GPI IgG as an independent predictor of low ABI (P=0.04).
Conclusions:
- Anti-beta 2-glycoprotein I (aβ2GPI) IgG antibodies are associated with impaired ABI in antiphospholipid syndrome (APS).
- This association suggests a potential role for aβ2GPI IgG in the pathogenesis of atherosclerosis within APS patients.
Introduction:
The patients with antiphospholipid syndrome (APS) associate an increased risk of atherosclerosis.
Objective:
To determine the predictors of an abnormal ankle-brachial index (ABI), surrogate measure of atherosclerosis, in patients with APS.
Methods:
The ABI was measured according to standard recommendations in 106 patients. Traditional cardiovascular risk factors were assessed in all cases. A large spectrum of APS antibodies was determined in 73 patients.
Results:
A total of 106 patients diagnosed with APS were included. 28.3% patients included were found to have low ABI. Anti-beta 2-glycoprotein I (aβ2GPI) IgG antibodies [4.00 (1.00-79.00) vs 3.00 (0.00-29.00) U/mL, P = 0.02] and antiprothrombin (aPT) IgM antibodies [4.50 (0.00-82.00) vs 3.00 (0.00-14.00) U/mL, P = 0.05] titers were found to be higher in patients with abnormal ABI. However, after multivariate regression analysis, only the aβ2GPI IgG titer remained predictor of low ABI (P = 0.04).
Conclusions:
aβ2GPI IgG associated with impaired ABI in patients with APS. This relation might reflect their involvement in the atherosclerosis occurrence.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Ankle Joint
Relative Risk
Decision Making: Traditional Method
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
Transcription Factors

